医疗机构重点监控药品的监管与思考  

Supervision and Consideration on Key Monitoring Drugs in Medical Institutions

作　　者：张敬一[1] 李泽[1] 王作君[1] 褚征[1] 

机构地区：[1]沈阳军区总医院药学部,沈阳110080

出　　处：《中国药师》2017年第11期2042-2045,共4页China Pharmacist

摘　　要：目的:加强医疗机构重点监控药品管理,促进临床合理用药,减少患者药品消耗费用。方法:建立重点监控药品目录、点评规范和监管机制,通过监管前后的指标对比,探讨出一套行之有效的监管办法。结果与结论:从重点监控药品新药引进"源头"上控制医疗机构药品类别,利用信息化手段对重点监控药品进行"实时"监控,采取重点监控药品处方点评和办公室会反馈对辅助用药"事后"监管,重点监控药品指标有明显好转,监管办法有效。Objective： To enhance the pharmaceutical administration of the key monitoring drugs, promote the rational drug use and reduce the drug consumption of patients. Methods： The key monitoring drugs directory was complied, and prescription comment was standardized, and the supervision management system was established. Through the comparison the indicators before and after the management intervention, a series of effective management methods were explored. Results and Conclusion： From the emphasized monitoring for the introduction of new key monitoring drugs, the drug categories in medical institutions were controlled from the source. Information means were used to perform the real-time monitoring for the key monitoring drugs. Drug prescription reviews and office feedbacks were carried out to supervise the complementary drugs afterwards. After the management intervention, the indicators of key monitoring drugs were improved significantly, suggesting the effectiveness of monitoring methods.

关 键 词：重点监控药品 合理用药 监管办法 

分 类 号：R952[医药卫生—药学]